Please wait while the formulary information is being retrieved.
ACULAR LS (KETOROLAC TROMETHAMINE)
- Post-op ocular inflammation
- Postoperative ocular pain
- Post-op photophobia
0.4 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day for up to 4 days following corneal refractive surgery
0.5 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day
0.4 % eye drops
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day for up to 4 days following corneal refractive surgery
Postoperative ocular pain
- Instill 1 drop into left eye by ophthalmic route 4 times per day for up to 4 days following corneal refractive surgery
- Instill 1 drop into right eye by ophthalmic route 4 times per day forup to 4 days following corneal refractive surgery
- Instill 1 drop into both eyes by ophthalmic route 4 times per day forup to 4 days following corneal refractive surgery
- Instill 1 drop into affected eye(s) by ophthalmic route 4 times per day for up to 4 days following corneal refractive surgery
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Corneal degeneration
- Corneal erosion
- Diabetes mellitus
- Dry eye
- Hemophilia
- Increased risk of bleeding due to coagulation disorder
- Rheumatoid arthritis
ACULAR LS (KETOROLAC TROMETHAMINE)
- Post-op ocular inflammation
- Postoperative ocular pain
- Post-op photophobia
- None
- Blurred vision
- Conjunctival hemorrhage
- Conjunctival hyperemia
- Headache disorder
- Infiltrate of cornea
- Ocular hypertension
- Ocular pain
More Frequent
Severe
Less Severe
- Keratitis
- Contact dermatitis
- Ocular irritation
- Ocular itching
- Ocular redness
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Asthma exacerbation
- Bronchospastic pulmonary disease
- Corneal erosion
- Corneal ulcer
- Impaired wound healing
- Ocular hemorrhage
- Perforation of cornea
Less Severe
- Corneal dystrophy
- Corneal edema
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Ketorolac (Ophthalmic)
Safety and efficacy not established in pediatrics age < 3 years.
- 1 Day – 3 Years
- Safety and efficacy not established in pediatrics age < 3 years.
Ketorolac (ophth)
- Severity Level:
2
- Additional Notes: Insufficient human data avail; animal data do not sug dev tox
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Ketorolac (ophth)
Systemic absorption likely minimal;Oral product excreted
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Systemic absorption likely minimal;Oral product excreted |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Post-op ocular inflammation | |
H57.8 | Other specified disorders of eye and adnexa |
Post-op photophobia | |
H53.14 | Visual discomfort |
H53.141 | Visual discomfort, right eye |
H53.142 | Visual discomfort, left eye |
H53.143 | Visual discomfort, bilateral |
H53.149 | Visual discomfort, unspecified |
Postoperative ocular pain | |
H57.1 | Ocular pain |
H57.10 | Ocular pain, unspecified eye |
H57.11 | Ocular pain, right eye |
H57.12 | Ocular pain, left eye |
H57.13 | Ocular pain, bilateral |
0-9 | A-Z |
---|---|
H53.14 | Visual discomfort |
H53.141 | Visual discomfort, right eye |
H53.142 | Visual discomfort, left eye |
H53.143 | Visual discomfort, bilateral |
H53.149 | Visual discomfort, unspecified |
H57.1 | Ocular pain |
H57.10 | Ocular pain, unspecified eye |
H57.11 | Ocular pain, right eye |
H57.12 | Ocular pain, left eye |
H57.13 | Ocular pain, bilateral |
H57.8 | Other specified disorders of eye and adnexa |
Formulary Reference Tool